Acetyl-keto-β-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells

British Journal of Pharmacology

Volumn 148, Issue 8, 2006, Pages 1099-1107

  Liu, Jian Jun ^a   Huang, Baohua ^a   Hooi, Shing Chuan ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Acetyl keto boswellic acid; Cell cycle; Colon cancer; Cyclin; Cyclin dependent kinase; p21; p53

Indexed keywords

ACETYL KETO BETA BOSWELLIC ACID; BOSWELLIC ACID; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PHOSPHOPROTEIN; PHOSPHORYLATED RETINOBLASTOMA PROTEIN; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROTECTION; CELL STRAIN HCT116; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; TRITERPENES; UP-REGULATION;

EID: 33747099596     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706817     Document Type: Article

References (34)

1. CAPUTI, M., RUSSO, G., ESPOSITO, V., MANCINI, A. & GIORDANO, A. (2005). Role of cell-cycle regulators in lung cancer. J. Cell Physiol., 205, 319-327.
2. GARTEL, A.L. & RADHAKRISHNAN, S.K. (2005). Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res., 65, 3980-3985.
3. GARTEL, A.L. & TYNER, A.L. (2002). The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther., 1, 639-649.
4. GERHARDT, H., SEIFERT, F., BUVARI, P., VOGELSANG, H. & REPGES, R. (2001). Therapy of active Crohn disease with Boswellia serrata extract H 15]. Z. Gastroenterol., 39, 11-17.
5. GLASER, T., WINTER, S., GROSCURTH, P., SAFAYHI, H., SAILER, E.R., AMMON, H.P., SCHABET, M. & WELLER, M. (1999). Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br. J. Cancer, 80, 756-765.
6. GUPTA, I., GUPTA, V., PARIHAR, A., GUPTA, S., LUDTKE, R., SAFAYHI, H. & AMMON, H.P. (1998). Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur. J. Med. Res., 3, 511-514.
7. GUPTA, I., PARIHAR, A., MALHOTRA, P., GUPTA, S., LUDTKE, R., SAFAYHI, H. & AMMON, H.P. (2001). Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta. Med., 67, 391-395.
8. GUPTA, I., PARIHAR, A., MALHOTRA, P., SINGH, G.B., LUDTKE, R., SAFAYHI, H. & AMMON, H.P. (1997). Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur. J. Med. Res., 2, 37-43.
9. HAN, R. (1994a). Highlight on the studies of anticancer drugs derived from plants in China. Stem. Cells, 12, 53-63.
10. HAN, R. (1994b). Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China. Chin. Med. Sci. J., 9, 61-69.
11. HARPER, J.W. & ELLEDGE, S.J. (1996). Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev., 6, 56-64.
12. HOERNLEIN, R.F., ORLIKOWSKY, T., ZEHRER, C., NIETHAMMER, D., SAILER, E.R., SIMMET, T., DANNECKER, G.E. & AMMON, H.P. (1999). Acetyl-11-keto-beta- boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. J. Pharmacol. Exp. Ther., 288, 613-619.
13. HUANG, M.T., BADMAEV, V., DING, Y., LIU, Y., XIE, J.G. & HO, C.T. (2000). Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors, 13, 225-230.
14. HUNTER, T. & PINES, J. (1994). Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
15. JANSSEN, G., BODE, U., BREU, H., DOHRN, B., ENGELBRECHT, V. & GOBEL, U. (2000). Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors. Klin. Padiatr., 212, 189-195.
16. JING, Y., NAKAJO, S., XIA, L., NAKAYA, K., FANG, Q., WAXMAN, S. & HAN, R. (1999). Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leuk. Res., 23, 43-50.
17. KIELA, P.R., MIDURA, A.J., KUSCUOGLU, N., JOLAD, S.D., SOLYOM, A.M., BESSELSEN, D.G., TIMMERMANN, B.N. & GHISHAN, F.K. (2005). Effects of Boswellia serrata in mouse models of chemically induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol., 288, G798-G808.
18. LE, H.V., MINN, A.J. & MASSAGUE, J. (2005). Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells. J. Biol. Chem., 280, 32018-32025.
19. LIU, J.J., NILSSON, A., OREDSSON, S., BADMAEV, V. & DUAN, R.D. (2002a). Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int. J. Mol. Med., 10, 501-505.
20. LIU, J.J., NILSSON, A., OREDSSON, S., BADMAEV, V., ZHAO, W.Z. & DUAN, R.D. (2002b). Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis, 23, 2087-2093.
21. LIU, J.J., ZHANG, J., RAMANAN, S., JULIAN, J., CARSON, D.D. & HOOI, S.C. (2004). Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs. Carcinogenesis, 25, 873-879.
22. MALUMBRES, M. & BARBACID, M. (2001). To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer, 1, 222-231.
23. MCGOWAN, C.H. (2003). Regulation of the eukaryotic cell cycle. Prog. Cell. Cycle Res., 5, 1-4.
24. MORRIS, E.J. & DYSON, N.J. (2001). Retinoblastoma protein partners. Adv. Cancer Res., 82, 1-54.
25. PARK, Y.S., LEE, J.H., HARWALKAR, J.A., BONDAR, J., SAFAYHI, H. & GOLUBIC, M. (2002). Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2. Adv. Exp. Med. Biol., 507, 387-393.
26. PAYTON, M. & COATS, S. (2002). Cyclin E2, the cycle continues. Int. J. Biochem. Cell. Biol., 34, 315-320.
27. SAFAYHI, H., MACK, T. & AMMON, H.P. (1991). Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol., 41, 1536-1537.
28. SHAO, Y., HO, C.T., CHIN, C.K., BADMAEV, V., MA, W. & HUANG, M.T. (1998). Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta. Med., 64, 328-331.
29. SHARMA, M.L., BANI, S. & SINGH, G.B. (1989). Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int. J. Immunopharmacol., 11, 647-652.
30. STREFFER, J.R., BITZER, M., SCHABET, M., DICHGANS, J. & WELLER, M. (2001). Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. Neurology, 56, 1219-1221.
31. SYROVETS, T., GSCHWEND, J.E., BUCHELE, B., LAUMONNIER, Y., ZUGMAIER, W., GENZE, F. & SIMMET, T. (2005). Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. J. Biol. Chem., 280, 6170-6180.
32. TEMPLE, W.J., SUGARBAKER, E.V., THORNTHWAITE, J.T., HENSLEY, G.T. & KETCHAM, A.S. (1980). Correlation of cell cycle analysis with Duke's staging in colon cancer patients. J. Surg. Res., 28, 314-318.
33. WINKING, M., SARIKAYA, S., RAHMANIAN, A., JODICKE, A. & BOKER, D.K. (2000). Boswellic acids inhibit glioma growth: a new treatment option? J. Neurooncol., 46, 97-103.
34. ZHAO, W., ENTSCHLADEN, F., LIU, H., NIGGEMANN, B., FANG, Q., ZAENKER, K.S. & HAN, R. (2003). Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detect. Prev., 27, 67-75.